Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rivastigmine long-acting percutaneous absorption patch and preparation method thereof

An absorption enhancer, long-acting technology, applied in the field of medicine, can solve problems such as complex patch structure, achieve low cost, easy to use, and increase the effect of high release

Pending Publication Date: 2022-04-12
SHENYANG PHARMA UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The patch of this patent still needs to use a controlled-release film to control the release of rivastigmine, the patch structure is relatively complex, and the anti-oxidant DL-α-tocopherol needs to be added to the drug-containing pressure-sensitive adhesive layer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rivastigmine long-acting percutaneous absorption patch and preparation method thereof
  • Rivastigmine long-acting percutaneous absorption patch and preparation method thereof
  • Rivastigmine long-acting percutaneous absorption patch and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Dissolve 0.1 mol of rivastigmine free base in 100 ml of acetone, add 0.1 mol of n-butyric acid under stirring, continue to stir for 2 hours, and dry the solvent by rotary evaporation to obtain rivastigmine n-butyrate ionic liquid.

Embodiment 2

[0046] Dissolve 0.1 mol of rivastigmine free base in 100 ml of acetone, add 0.1 mol of n-octanoic acid under stirring, continue to stir for 2 hours, and rotatively evaporate to dry the solvent to obtain n-octanoic acid rivastigmine ionic liquid.

Embodiment 3

[0048] Dissolve 0.1 mol of rivastigmine free base in 100 ml of acetone, add 0.1 mol of lauric acid under stirring, continue stirring for 2 hours, and dry the solvent by rotary evaporation to obtain rivastigmine lauric acid ionic liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a rivastigmine long-acting percutaneous absorption patch, and belongs to the technical field of medicines. The percutaneous absorption patch is suitable for being applied for at least three days, and the patch is composed of a backing layer, a medicine-carrying pressure-sensitive adhesive layer and an anti-sticking layer. The drug-loading pressure-sensitive adhesive layer comprises rivastigmine free alkali or organic acid ionic liquid thereof, a pressure-sensitive adhesive and a percutaneous absorption enhancer. Wherein the weight of the rivastigmine free alkali or the organic acid ionic liquid of the rivastigmine free alkali accounts for 5-45wt% of the total weight of the drug-loaded pressure-sensitive adhesive layer, the weight of the pressure-sensitive adhesive accounts for 50-90wt% of the total weight of the pressure-sensitive adhesive layer, and the dosage of the percutaneous absorption enhancer accounts for 1-20wt% of the total weight of the pressure-sensitive adhesive layer. Wherein in the rivastigmine organic acid ionic liquid, the molar ratio of rivastigmine free alkali to different organic acids is (0.5: 1)-(2: 1). In the patch provided by the invention, the cumulative permeation amount of rivastigmine within 72 hours can reach 2.8 mg / cm < 2 >. The patch is simple in preparation technology, low in cost, capable of releasing medicine at constant speed, safe, effective, good in stability and convenient to use.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a rivastigmine long-acting percutaneous absorption patch, a preparation method thereof and an application thereof. Background technique [0002] Alzheimer's disease is a progressive, irreversible neurodegenerative disease and the most common cause of progressive mental decline in people over the age of 65. Alzheimer's disease is characterized by three main groups of symptoms: cognitive dysfunction, psychiatric symptoms and behavioral disturbances, and deterioration of activities of daily living and behavior. These deficits develop over time and are often accompanied by behavioral disturbances such as aggression, depression, confusion, and wandering. In 2018, the global prevalence of Alzheimer's disease was 50 million, and the global economic loss was close to US$1 trillion. The Population Division of the United Nations predicts that by 2050, the population over the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/70A61K31/27A61K47/32A61P25/28
Inventor 方亮权鹏刘超才煜
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com